Modified tuberculosis antigens

Details for Australian Patent Application No. 2011209399 (hide)

Owner GlaxoSmithKline Biologicals s.a. Glaxo Group Limited

Inventors Blais, Normand; Brown, James; Gelinas, Anne-Marie; Mettens, Pascal; Murphy, Dennis

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011209399

PCT Pub. Number WO2011/092253

Priority 61/298,710 27.01.10 US

Filing date 27 January 2011

Wipo publication date 4 August 2011

International Classifications

A61K 39/04 Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/092253 Priority application(s): WO2011/092253

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011209407-Probiotic composition for use in the treatment of bowel inflammation

2011209396-Method to start-up a process to make expandable vinyl aromatic polymers